CSET’s Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by the Bulletin of the Atomic Scientists. The article discusses how rapidly advancing biotechnology and AI are reshaping biosecurity, highlighting both the promise of new scientific tools and the need for stronger, adaptive safeguards.

The Diplomat interviews William C. Hannas and Huey-Meei Chang on myths and misinformation that have persisted in the policy ecosystem around China's development of AI.

CSET’s Kathleen Curlee shared her expert analysis in an article published by TIME. The article discusses the growing hazards posed by space debris, highlighting a recent incident in which China’s Shenzhou-20 spacecraft was struck by orbital debris, delaying the return of its crew from the Tiangong Space Station.

CSET’s Steph Batalis shared her expert analysis in an op-ed published by The National Interest. In her piece, she discusses how proposed federal research funding cuts threaten not only U.S. scientific progress but also the safety and security of biological research. These cuts would weaken the safeguards, oversight, and resources that protect both scientists and the public from accidents and biological threats.

CSET’s Sam Bresnick shared his expert analysis in an op-ed published by Nikkei Asia. In his piece, he explores the evolving role of U.S. technology companies in international security, particularly in times of conflict, and examines the contrast between their decisive support for Ukraine during Russia’s 2022 invasion and the uncertainty surrounding their potential response in a Taiwan-China crisis.

Newsweek profiled a CSET report on China's alternative approaches to developing artificial general intelligence.

CSET's Steph Batalis shared her expert analysis in an op-ed published by DefenseOne. In her piece, she highlights how the United States’ faltering response to the ongoing measles outbreak reveals serious vulnerabilities in the nation’s public health and biodefense infrastructure.

Jack Corrigan and Vikram Venkatram shared their expert analysis in an op-ed published by The National Interest. In their piece, they examine the political and legal controversy surrounding the Biden administration’s draft guidance on “march-in rights” under the Bayh-Dole Act, which could allow federal agencies to lower drug prices by reclaiming patents on taxpayer-funded inventions when they are not reasonably accessible to the public.

CSET's Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by The Bulletin of the Atomic Scientists. The article explores discusses the complexities and challenges of screening DNA synthesis orders to prevent misuse of potentially dangerous genetic sequences.

Mia Hoffmann and Owen J. Daniels shared their expert analysis in an op-ed published by Tech Policy Press. In their piece, they highlight the evolving role of the European Union in the global AI policy ecosystem and the potential consequences of its shifting stance on regulation.